Bioequivalence Study of Dr. Reddy's Divalproex Sodium Capsules (Sprinkle), 125 mg Under Fasting Conditions
Status:
Completed
Trial end date:
2007-03-01
Target enrollment:
Participant gender:
Summary
An open label, balanced, randomized, two-treatment, two-period, two-sequence, single dose,
crossover, bioequivalence study of Divalproex Sodium coated particles in capsules 125 mg with
Depakote® Sprinkle125 mg capsules in healthy, adult, human subjects under fasting conditions.